Gene · 634
Papers3,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Breast Cancer Tumor Microenvironment and Molecular Aberrations Hijack Tumoricidal Immunity. | Cancers (Basel) | 2022 | 35053449 | PubTator, text mining | PubMed |
| A comprehensive long-read isoform analysis platform and sequencing resource for breast cancer. | Sci Adv | 2022 | 35044822 | PubTator, text mining | PubMed |
| Data on plasma tumour and metabolism related proteins' potential in differentiation of HFpEF-PH from PAH and in prognosis of left heart failure patients with pulmonary hypertension. | Data Brief | 2022 | 35024391 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals upregulation of immune response pathways at the invasive tumour front of metastatic seminoma germ cell tumours. | Br J Cancer | 2022 | 35022523 | PubTator, text mining | PubMed |
| Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism. | Gut | 2022 | 35017197 | PubTator, text mining | PubMed |
| Insights into Modern Therapeutic Approaches in Pediatric Acute Leukemias. | Cells | 2022 | 35011701 | PubTator, text mining | PubMed |
| The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy. | Cancers (Basel) | 2022 | 35008381 | PubTator, text mining | PubMed |
| Review on Optical Imaging Techniques for Multispectral Analysis of Nanomaterials. | Nanotheranostics | 2022 | 34976580 | PubTator, text mining | PubMed |
| Comprehensive mass spectrometry for development of proteomic biomarkers of intracranial aneurysms. | Talanta | 2022 | 34973552 | PubTator, text mining | PubMed |
| Role of lncRNA LIPE-AS1 in adipogenesis. | Adipocyte | 2022 | 34957921 | PubTator, text mining | PubMed |
| Development and validation of prognostic and diagnostic model for pancreatic ductal adenocarcinoma based on scRNA-seq and bulk-seq datasets. | Hum Mol Genet | 2022 | 34957503 | PubTator, text mining | PubMed |
| Nephrotoxicity evaluation of 3-monochloropropane-1,2-diol exposure in Sprague-Dawley rats using data-independent acquisition-based quantitative proteomics analysis. | Toxicol Lett | 2022 | 34915118 | PubTator, text mining | PubMed |
| Natural killer cells in liver transplantation: Can we harness the power of the immune checkpoint to promote tolerance? | Clin Transl Sci | 2022 | 34866338 | PubTator, text mining | PubMed |
| Distinct noncoding RNAs and RNA binding proteins associated with high-risk pediatric and adult acute myeloid leukemias detected by regulatory network analysis. | Cancer Rep (Hoboken) | 2022 | 34862757 | PubTator, text mining | PubMed |
| Antibody ligation of CEACAM1, CEACAM3, and CEACAM6, differentially enhance the cytokine release of human neutrophils in responses to Candida albicans. | Cell Immunol | 2022 | 34847408 | PubTator, text mining | PubMed |
| Emerging mutation patterns in SARS-CoV-2 variants. | Biochem Biophys Res Commun | 2022 | 34837837 | PubTator, text mining | PubMed |
| Genomic comparisons between hepatocarcinogenic and non-hepatocarcinogenic organophosphate insecticides in the mouse liver. | Toxicology | 2022 | 34813904 | PubTator, text mining | PubMed |
| Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma. | Melanoma Res | 2022 | 34753889 | PubTator, text mining | PubMed |
| Modulation of intrinsic inhibitory checkpoints using nano-carriers to unleash NK cell activity. | EMBO Mol Med | 2022 | 34725941 | PubTator, text mining | PubMed |
| Beyond liquid biopsy: Toward non-invasive assays for distanced cancer diagnostics in pandemics. | Biosens Bioelectron | 2022 | 34688113 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/634/papers?page=45